| Hazard Information | Back Directory | [Uses]
BET-IN-16 (Compound I) is a BET inhibitor. BET-IN-16 shows anticancer activity. BET-IN-16 inhibits prostate cancer cell growth, with IC50 values of 0.043 and 0.034 μM against LNCaP and 22Rv1 cells, respectively[1]. | [References]
[1] Ben Powell, et al. Combinational drug anticancer therapies. Patent, WO2022040512A1. |
|
|